| Brenda Leask, | |
|
7300 Klawock Hollis Hwy, Klawock, AK 99925 | |
| (907) 755-4987 | |
| (907) 826-2103 |
| Full Name | Brenda Leask |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 7300 Klawock Hollis Hwy, Klawock, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215470091 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Leask, Po Box 272, Klawock, AK 99925-0272 Ph: (907) 755-4987 | Brenda Leask, 7300 Klawock Hollis Hwy, Klawock, AK 99925 Ph: (907) 755-4987 |
News Archive
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
The discovery of the 'molecular switch' that causes inflammatory bowel disease (IBD) and Celiac disease, could lead to more effective new treatments for these life-changing auto-immune conditions, according to research from scientists at King's College London and University College London.
High antiretroviral therapy adherence, which has been shown to be a major predictor of HIV disease progression and survival, is now associated with lower health care costs, according to researchers at the Johns Hopkins Bloomberg School of Public Health.
Despite Cambodia's remarkable history in driving down HIV infections, a report released today on the future of AIDS in the country argues that future success is not guaranteed and the government needs to focus increasingly on wise prevention tactics and assume more of the financing of its AIDS program.
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is usually dramatic, the tumors often recur as the cancer becomes resistant to treatment.
› Verified 7 days ago
Paul England, Counselor Medicare: Not Enrolled in Medicare Practice Location: 655 South Summit Street, Klawock, AK 99925 Phone: 907-225-7825 | |
Reuben Chinana, Counselor Medicare: Not Enrolled in Medicare Practice Location: #1 5th St, Klawock, AK 99922 Phone: 907-225-7825 Fax: 907-225-1541 | |
Tammy Jackson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 655 South Summit Street, Klawock, AK 99925 Phone: 907-225-7825 | |
Sean Fred Tomkinson, LCSW Counselor Medicare: Medicare Enrolled Practice Location: 6345 G Street, Klawock, Klawock, AK 99925 Phone: 907-821-8092 | |
Jerrod Clark, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6340 G Street, Klawock, AK 99925 Phone: 502-226-0663 | |
Forest F Anderson, CFSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 13004 Klawock Hollis Highway, Klawock, AK 99925 Phone: 907-755-4800 Fax: 907-755-4908 |